StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Fair Value $1.29 (Jan 12, 2021)

<< Previous

Bullboard Posts

Next >>

Comment by MarketMoneyon Jan 13, 2021 10:59am

141 Views

Post# 32284587

RE:Fair Value $1.29 (Jan 12, 2021)

Olteanu007 wrote:
Morningstar's Analysis Summary. Valuation Jan 12, 2021. SZLS is at a 40% Discount. Fair Value $1.29 Last Close 0.77 cents. 1-Star Price > $10.96 . More info at: https://www.morningstar.ca/ca/report/stocks/analysis.aspx?t=0P00005S5S&lang=en-CA

Fair value is good for like mutual funds where you pay for the known value of a portofolio. For a stock, fair value not much a good reference as the real value of a stock is and will always be at the present moment which the market decide to be at! Fair or not! Stockmarket doesn't care! Supply amd demand is the key to understand the market fluctuation :-)

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market